Role of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation

Chinese Journal of Cancer Research

Volumn 25, Issue 2, 2013, Pages 143-154

  Wu, Jie ^a   Yang, Wei ^a   Yin, Shanshan ^a   Wu, Jinyu ^a   Wu, Wei ^a   Yan, Kun ^a   Chen, Minhua ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Contrast media; Liver metastases; Radiofrequency ablation; Ultrasonography

Indexed keywords

SONOVUE;

ADULT; ARTICLE; BILE LEAKAGE; BREAST CANCER; CANCER LOCALIZATION; CANCER SIZE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPH; ECHOGRAPHY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LOCAL RECURRENCE FREE SURVIVAL; LUNG CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; POSTOPERATIVE HEMORRHAGE; RADIOFREQUENCY ABLATION; RECURRENT CANCER; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR NECROSIS;

EID: 84883794697     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2013.01.02     Document Type: Article

References (35)

1. Stang A, Keles H, von Seydewitz C, et al. Percutanous and intraoperative ultrasound-guided radiofrequency ablation of hepatic tumours. Ultraschall Med 2007;28:181-8. (Pubitemid 46732449)
2. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009;19:1206-13.
3. Meloni MF, Andreano A, Laeseke PF, et al. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. Radiology 2009;253:861-9.
4. Chen MH, Wei Y, Yan K, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006;17:671-83. (Pubitemid 44392016)
5. Wu JY, Chen MH, Yan k, et al. Ultrasound-guided radiofrequency ablation in the treatment of liver metastases. Journal of Beijing Medical University 2001;33:449-51.
6. Bernatik T, Seitz K, Blank W, et al. Unclear focal liver lesions in contrast-enhanced ultrasonography - lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med 2010;31:577-81.
7. Dai Y, Chen MH, Fan ZH, et al. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res 2008;38:281-90. (Pubitemid 351193957)
8. Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153-61. (Pubitemid 30190524)
9. Dai Y, Chen MH, Yin SS, et al. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol 2007;42:596-603. (Pubitemid 47051837)
10. Albrecht T, Blomley MJ, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361-70. (Pubitemid 36514748)
11. Oldenburg A, Hohmann J, Foert E, et al. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005;26:277-84. (Pubitemid 41232709)
12. Solbiati L, Goldberg SN, Ierace T, et al. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999;211:643-9. (Pubitemid 29249457)
13. Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol 2004;14 Suppl 8:P34-42.
14. Minami Y, Kudo M, Kawasaki T, et al. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004;183:153-6. (Pubitemid 38789029)
15. Solbiati L, Ierace T, Tonolini M, et al. Guidance and control of percutaneous treatments with contrast-enhanced ultrasound. Eur Radiol 2003;13 Suppl 3:N87-90. (Pubitemid 38072476)
16. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005;56:66-73. (Pubitemid 41316489)
17. Chen MH, Yang W, Yan K, et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007;62:752-60.
18. Chen MH, Wu W, Yang W, et al. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy. J Ultrasound Med 2007;26:1055-63. (Pubitemid 47221836)
19. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-30. (Pubitemid 38971282)
20. Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients - mathematic model, overlapping mode, and electrode placement process. Radiology 2004;232:260-71. (Pubitemid 38787848)
21. Minami Y, Kudo M, Hatanaka K, et al. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010;30:759-64.
22. Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 2008;19:712-7.
23. Sørensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007;48:253-8. (Pubitemid 46589076)
24. Elias D, Baton O, Sideris L, et al. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004;11:500-5. (Pubitemid 40486731)
25. Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003;10:52-8.
26. Shirabe K, Takenaka K, Gion T, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997;84:1077-80. (Pubitemid 27359477)
27. Ambiru S, Miyazaki M, Isono T, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-9. (Pubitemid 29228409)
28. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-66. (Pubitemid 34547293)
29. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22, discussion 722-4.
30. Wernecke K, Rummeny E, Bongartz G, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991;157:731-9.
31. Glover C, Douse P, Kane P, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002;45:476-84. (Pubitemid 34407725)
32. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phaseinversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001;176:1191-8. (Pubitemid 32323261)
33. Yin SS, Chen MH, Yan K, et al. Role of gray-scale contrast enhanced ultrasound in diagnosis of liver metastasis. Zhonghua Chao Sheng Ying Xiang Xue Za Zhi (in Chinese) 2005;14:354-8.
34. Konopke R, Bunk A, Kersting S. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall Med 2008;29 Suppl 4:S203-9.
35. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-66. (Pubitemid 32880383)